faculty
Karl Doghramji, MD, FAASM, DFAPA
Professor of Psychiatry, Neurology, and Medicine
Sidney Kimmel Medical College
Director, Jefferson Sleep Disorders Center
Thomas Jefferson University
Philadelphia, Pennsylvania
Paul P. Doghramji, MD, FAAFP
Senior Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, Pennsylvania

Target Audience

The educational design of this activity addresses the needs of sleep medicine clinicians, pulmonologists, neurologists, cardiologists, and psychiatrists (MDs, NPs, PAs).

Program Overview

Join sleep specialist Dr. Karl Doghramji for a simulated morning in the sleep medicine clinic, where a series of patient encounters and interdisciplinary consultations highlight the challenges of recognizing and diagnosing CDH, including narcolepsy and IH. Through clinical scenarios, he will explore approaches to evaluating persistent excessive daytime sleepiness, differentiating IH from other sleep disorders, and interpreting polysomnography and Multiple Sleep Latency Test findings.

Educational Objectives

After completing this activity, the participant should be better able to:

  1. Identify patients with narcolepsy or idiopathic hypersomnia promptly based on symptoms, sleep evaluations, and appropriate ancillary testing
  2. Describe recently published evidence and practical prescribing considerations for the pharmacologic treatment of narcolepsy or idiopathic hypersomnia
  3. Individualize treatment plans for narcolepsy or idiopathic hypersomnia to reflect daytime and nighttime treatment goals, risks of sodium-associated negative clinical outcomes, and shared clinical decision making

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Reciprocity Statement

The ANCC’s Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal.

Integritas Contact Information

For more information about the approval of this program, please contact Integritas at info@exchangecme.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must take the pretest, view the content, pass the posttest with a 70% or higher, and complete the evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas.  All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Karl Doghramji, MD, FAASM, DFAPA: Consulting Fees: Axsome, Centessa, Harmony, Jazz; Contracted Research: Inspire, Nyxoah, Respicardia, Sommetrics; Ownership Interest (Stocks): Merck

Paul P. Doghramji, MD, FAAFP: Consulting Fees: Tonix; Speakers’ Bureau: Amgen, Axsome, J&J, Lilly, Otsuka, Pfizer, Tonix

The planners and managers have no relevant financial relationships with ineligible companies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Begin Activity
available resources
linked resources
Suggested Reading
A Day in the Life™

A Day in the Life of a Sleep Specialist

Comprehensive Care for Narcolepsy and Idiopathic Hypersomnia